Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Amresh Chopdar a East Surrey Hospital, Redhill, Surrey RH1
5RH, b Queen's University and Royal Victoria Hospital, Belfast, c Doheny Retina Institute, Keck School of Medicine,
University of Southern California, Los Angeles, CA, USA Correspondence to: A
Chopdar vision@nearpoint.fsnet.co.uk
| The first 150 words of the full text of this article appear below. |
Age related macular degeneration is an increasing problem worldwide. Current treatment options can delay progression, and research continues into ways of reversing retinal damage
An epidemic of "ageing" is impending in the Western
world. According to the latest predictions released by the United
Nations, the number of people aged over 60 will triple from 606 million worldwide in 2000 to nearly 2 billion by 2050. The increase in the
population aged over 80 is expected to be more than fivefold, from 69 million in 2000 to 379 million by 2050. People aged over 60 constitute
about 20% of the population in more developed regions of the world; by
2050 they will probably account for 33%.1 The United
Kingdom is predicted to have about 16 million people over the age of 60 by 2040.2 One major implication of this demographic change
is the emergence of conditions that are directly related to ageing. Age
related macular degeneration is already the leading cause of blindness
in the
Read all Rapid Responses